Collegium Pharmaceutical, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Collegium Pharmaceutical, Inc. (COLL) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $200.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2024-08-08
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2023-12-31 was $123.00K.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2022-09-30 was $155.00K, a 36.99% decline year-over-year.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2022-06-30 was -$43.00K.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2022-03-31 was $148.00K, a 73.57% decline year-over-year.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $176.00K.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2021 was $72.00K, a 75.43% decline from fiscal 2020.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2020 was $293.00K, a 118.66% increase from fiscal 2019.
- Collegium Pharmaceutical, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2019 was $134.00K, a 95.89% decline from fiscal 2018.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2024-06-30 | $200.00K 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $176.00K 10-K · filed 2024-02-22 | ||
| 2023-09-30 | $53.00K 10-Q · filed 2023-11-07 | |||
| 2022-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $112.00K derived: sum of 2 quarters · filed 2023-11-07 | $260.00K 10-Q · filed 2023-11-07 | $31.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $105.00K 10-Q · filed 2023-08-03 | -$124.00K derived: sum of 3 quarters · filed 2024-02-22 | $122.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $148.00K 10-Q · filed 2023-05-04 | -$81.00K derived: sum of 2 quarters · filed 2024-02-22 | $165.00K derived: sum of 3 quarters · filed 2024-02-22 | -$340.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $17.00K derived: sum of 2 quarters · filed 2024-02-22 | -$488.00K derived: sum of 3 quarters · filed 2024-02-22 | $72.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$259.00K derived: sum of 2 quarters · filed 2022-11-03 | $301.00K 10-Q · filed 2022-11-03 | -$144.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $55.00K 10-Q · filed 2022-08-04 | -$390.00K derived: sum of 3 quarters · filed 2023-02-23 | -$1.21M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $560.00K 10-Q · filed 2022-05-10 | $115.00K derived: sum of 2 quarters · filed 2023-02-23 | -$702.00K derived: sum of 3 quarters · filed 2023-02-23 | $461.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$1.26M derived: sum of 2 quarters · filed 2023-02-23 | -$99.00K derived: sum of 3 quarters · filed 2023-02-23 | $293.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | -$817.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $346.00K derived: sum of 2 quarters · filed 2021-11-04 | $738.00K 10-Q · filed 2021-11-04 | $320.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.55M 10-Q · filed 2021-08-05 | $1.14M derived: sum of 3 quarters · filed 2022-02-24 | $1.18M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $392.00K 10-Q · filed 2021-05-06 | -$26.00K derived: sum of 2 quarters · filed 2022-02-24 | $14.00K derived: sum of 3 quarters · filed 2022-02-24 | -$284.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$378.00K derived: sum of 2 quarters · filed 2022-02-24 | -$676.00K derived: sum of 3 quarters · filed 2022-02-24 | $134.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$258.00K derived: sum of 2 quarters · filed 2020-11-05 | $552.00K 10-Q · filed 2020-11-05 | $2.36M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $512.00K 10-Q · filed 2020-08-05 | $2.32M derived: sum of 3 quarters · filed 2021-02-25 | $2.59M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $810.00K 10-Q · filed 2020-05-07 | $2.62M derived: sum of 2 quarters · filed 2021-02-25 | $2.89M derived: sum of 3 quarters · filed 2021-02-25 | $3.94M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.08M derived: sum of 2 quarters · filed 2021-02-25 | $3.13M derived: sum of 3 quarters · filed 2021-02-25 | $3.26M 10-K · filed 2021-02-25 |
| 2018-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.33M derived: sum of 2 quarters · filed 2019-11-06 | $1.46M 10-Q · filed 2019-11-06 | $1.57M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.18M 10-Q · filed 2019-08-07 | $1.30M derived: sum of 3 quarters · filed 2020-02-27 | $1.10M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $129.00K 10-Q · filed 2019-05-08 | $248.00K derived: sum of 2 quarters · filed 2020-02-27 | $41.00K derived: sum of 3 quarters · filed 2020-02-27 | $246.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$88.00K derived: sum of 2 quarters · filed 2020-02-27 | $117.00K derived: sum of 3 quarters · filed 2020-02-27 | $216.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | -$207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$2.00K derived: sum of 2 quarters · filed 2018-11-08 | $97.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $304.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $99.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $81.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |